Creatine Supplementation During GLP-1a Therapy
Recruiting
N/A
Interventional Study
Sarcopenia
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 40 (estimated)
- Sponsor
- University of Saskatchewan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Starting GLP-1 agonist therapy
* 18 years of age or older
Exclusion Criteria:
* Positive answers to a screening questionnaire for physical activity safety (the Get Active Questionnaire)
Contacts